- Martin Shkreli Reaches $28 Million Deal with Blue Cross Law & Crime
- Companies founded by Pharma Bro Martin Shkreli will pay up to $28M in class-action settlement over Daraprim price hike CNBC
- Blue Cross of Minnesota to settle with ‘Pharma Bro’ Martin Shkreli’s former drug company Minneapolis Star Tribune
- Shkreli’s former drug company to settle antitrust class action Reuters
- View Full Coverage on Google News
Martin Shkreli Reaches $28 Million Deal with Blue Cross – Law & Crime
